查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1819931

2025-2033 年病毒灭活市场报告（按产品、应用、最终用途和地区）

Viral Inactivation Market Report by Product, Application, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球病毒灭活市场规模达 6.917 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 14.797 亿美元，2025-2033 年期间的成长率 (CAGR) 为 8.38%。

生物治疗产品可能含有病毒，或在生产过程中受到污染。病毒是传染性颗粒，会侵入细胞并增殖，导致各种疾病。因此，病毒灭活技术被广泛用于抑制病毒外壳蛋白并降解病毒内的核酸。目前，全球各地根据病毒的特性和生物治疗产品的类型，提供不同的病毒灭活方法。例如，在医院和其他重要的公共和军事环境中，杀菌（UVC）光照射有助于灭活病毒。

病毒灭活市场趋势：

人体血液是用于预防和治疗危及生命疾病的药物来源之一。人们日益担忧血源性病毒透过血浆衍生药物传播，这是影响全球病毒灭活需求的重要因素之一。目前，已有多种病毒灭活程序用于确保血浆衍生蛋白溶液的安全性。此外，许多国家的管理机构在生物治疗产品开发的早期阶段就引入了严格的监管标准。这些标准正在不断提升病毒灭活的需求，以确保这些产品的品质、安全性和有效性，从而降低交叉污染的风险。此外，食品和饮料 (F&B) 行业正在采用改进的病毒灭活技术和产品，以帮助控制肠病毒的传播并确保产品安全。这与超临界流体、气体等离子体和脉衝电场等新物理方法的发展相结合，预计将提高病毒灭活的可靠性、便利性和适用性，从而推动市场发展。

本报告回答的关键问题

  • 病毒灭活市场有多大？病毒灭活市场未来前景如何？
  • 推动病毒灭活市场的关键因素有哪些？
  • 全球病毒灭活市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球病毒灭活市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 试剂和试剂盒
  • 系统
  • 服务

第七章：市场区隔：依应用

  • 疫苗和治疗学
  • 干细胞产品
  • 血液和血液製品
  • 纸巾及纸巾製品
  • 细胞和基因治疗

第 8 章：市场区隔：最终用途别

  • 製药和生物技术公司
  • 合约研究组织
  • 学术及研究机构
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Charles River Laboratories
    • Merck KGaA
    • Parker Hannifin Corp
    • Rad Source Technologies
    • Sartorius AG
    • SGS SA
    • Terumo Corporation
    • Texcell
    • Vironova AB
    • WuXi AppTec
Product Code: SR112025A4115

The global viral inactivation market size reached USD 691.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,479.7 Million by 2033, exhibiting a growth rate (CAGR) of 8.38% during 2025-2033.

Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.

Viral Inactivation Market Trends:

Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.

Key Market Segmentation:

Breakup by Product:

  • Reagents and Kits
  • Systems
  • Services

Breakup by Application:

  • Vaccines and Therapeutics
  • Stem Cell Products
  • Blood and Blood Products
  • Tissue and Tissue Products
  • Cellular and Gene Therapy

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • CROs
  • Academic and Research Institutes
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.

Key Questions Answered in This Report

  • 1.How big is the viral inactivation market?
  • 2.What is the future outlook of viral inactivation market?
  • 3.What are the key factors driving the viral inactivation market?
  • 4.Which are the leading companies in the global viral inactivation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viral Inactivation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Vaccines and Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stem Cell Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood and Blood Products
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Tissue and Tissue Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cellular and Gene Therapy
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CROs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Merck KGaA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Parker Hannifin Corp
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Rad Source Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Sartorius AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 SGS SA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Terumo Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Texcell
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Vironova AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 WuXi AppTec
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
  • Figure 2: Global: Viral Inactivation Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
  • Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
  • Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Viral Inactivation Market: Competitive Structure
  • Table 7: Global: Viral Inactivation Market: Key Players